TY - JOUR
T1 - Stimulation of calcitonin secretion by calcium receptor activators
T2 - Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin
AU - Lavigne, Jeffrey R.
AU - Zahradnik, Richard J.
AU - Conklin, Rebecca L.
AU - Lambert, Lyssa D.
AU - Logan, Mary A.
AU - Parihar, Ashutosh
AU - Fox, John
PY - 1998
Y1 - 1998
N2 - Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of <7%. Gel filtration chromatography of rat plasma and rat medullary thyroid carcinoma 44-2 cell media showed that the vast majority of immunoreactivity coeluted with calcitonin standard. In 44-2 cells, increasing extracellular Ca2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca2+ receptor.
AB - Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of <7%. Gel filtration chromatography of rat plasma and rat medullary thyroid carcinoma 44-2 cell media showed that the vast majority of immunoreactivity coeluted with calcitonin standard. In 44-2 cells, increasing extracellular Ca2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca2+ receptor.
KW - Calcimimetics
KW - Calcitonin
KW - Immunoradiometric assay
KW - Rat
KW - Rat medullary thyroid carcinoma 44-2 cells
UR - http://www.scopus.com/inward/record.url?scp=0032469139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032469139&partnerID=8YFLogxK
U2 - 10.1385/ENDO:9:3:293
DO - 10.1385/ENDO:9:3:293
M3 - Article
C2 - 10221596
AN - SCOPUS:0032469139
SN - 1355-008X
VL - 9
SP - 293
EP - 301
JO - Endocrine
JF - Endocrine
IS - 3
ER -